Sanders Holds Roundtable Discussion With State of the Union Essay Contest Finalists
MONTPELIER, Vt., Feb. 16 – U.S. Sen. Bernie Sanders (I-Vt.) held a roundtable discussion at the Vermont State House on Saturday afternoon with the twenty finalists of his ninth annual State of the Union essay contest. The contest gives Vermont high school students an opportunity to describe which issues they would prioritize if they were president. “Each year, I look
Sanders Statement on Government Funding Deal
WASHINGTON, Feb. 14 – Sen. Bernie Sanders (I-Vt.) issued the following statement after voting for the agreement to fund the federal government: “While I have concerns about aspects of this bill, I will vote for it because I cannot turn my back on the two million federal employees and private contract workers who would be forced, again, to work without pay.
Sanders, DeFazio Introduce Bill to Expand Social Security
WASHINGTON, Feb. 13 – Sen. Bernie Sanders (I-Vt.) and Rep. Peter DeFazio (D-Ore.) introduced legislation Wednesday to expand Social Security benefits and strengthen the retirement program for generations to come. “It is time to expand Social Security, not cut it,” Sanders said. “At a time when more than half of older Americans over the age of 55 have no retirement
Sanders and Leahy Highlight Important Provisions for Vermont in Public Lands Legislation
WASHINGTON, Feb. 12 – Senators Bernie Sanders (I-Vt.) and Patrick Leahy (D-Vt.) announced that the Senate passed the Natural Resources Management Act on Tuesday evening by a 92-8 vote. This comprehensive public lands bill includes two provisions of particular importance to Vermonters. The bill permanently reauthorizes the Land and Water Conservation Fund (LWCF). Congress created the LWCF in 1965 to
Sanders Asks What Impact $375,000 Drug Will Have on Taxpayers
WASHINGTON, Feb. 6 – Sen. Bernie Sanders (I-Vt.) demanded answers Wednesday from the Department of Health and Human Services and the U.S. Centers for Medicare and Medicaid Services about the cost to taxpayers of Catalyst Pharmaceuticals’ drug Firdapse. Catalyst recently announced an annual list price of $375,000 for the medication, which patients previously received for free from Jacobus Pharmaceutical. “I am writing to